Anonymous ID: 838467 July 19, 2022, 5:20 p.m. No.16765716   🗄️.is đź”—kun   >>5735 >>6124

https://mobile.twitter.com/Prole53/status/1548692867186581504

 

Prole53

@Prole53

🇫🇷 TourDeFrance Victor Lafay, 26, retires.

I find it hard to breathe.I lack oxygen,I have pain in all my legs,no strength. All the COVID tests are negative, it could be something else We are many in the group who have the same symptoms,💉💉💉

Anonymous ID: 838467 July 19, 2022, 5:23 p.m. No.16765734   🗄️.is đź”—kun

https://mobile.twitter.com/cynrojasla/status/1548363955763982337

 

Cynthia Rojas

@cynrojasla

Last week on July 12 Ferrer said "union partners… are urging us to move much more quickly" because they have concerns.

 

Why does Ferrer listen to unions and not LA doctors?

 

Isn't it her job to communicate to unions that drs say covid is not a concern? It's all backwards.

Anonymous ID: 838467 July 19, 2022, 5:25 p.m. No.16765745   🗄️.is đź”—kun

https://www.axios.com/2022/06/30/pfizer-universal-covid-vaccine-testing

 

Pfizer to begin testing universal coronavirus vaccines

 

Pfizer and its partner BioNTech plan to start clinical trials of pan-coronavirus vaccines in the second half of the year, BioNTech officials said in an investor presentation on Wednesday.

 

Driving the news: The company said it wants to provide "durable variant protection," according to Reuters, which first reported the news.

 

Why it matters: Creating a vaccine that works against a variety of coronaviruses, including COVID-19, represents a holy grail — particularly as new variants threaten to outrun our current arsenal of vaccines.

 

State of play: Universal vaccines have been studied with limited success for years, but they are gaining renewed investment and research interest.

 

A pan-coronavirus vaccine, being developed at the Walter Reed Army Institute of Research, was planned for a Phase 1 clinical trial in April, CNN reported.

The NIH announced this week the start of a Phase 1 clinical trial to test the safety of a universal flu vaccine candidate, as well as its ability to prompt immune responses.

"The scientific community is making progress on this pressing global health priority," said NIAID director Anthony Fauci in a statement.

Be smart: As Axios' Caitlin Owens wrote last year, some experts say making a universal coronavirus vaccine may be easier than making a universal flu vaccine, especially given all that's been learned over the last two years.

Anonymous ID: 838467 July 19, 2022, 5:27 p.m. No.16765757   🗄️.is đź”—kun   >>5842 >>5871

https://www.fda.gov/food/cfsan-constituent-updates/fda-announces-temporary-flexibility-policy-regarding-certain-labeling-requirements-foods-humans

 

FDA Announces Temporary Flexibility Policy Regarding Certain Labeling Requirements for Foods for Humans During COVID-19 Pandemic

 

Constituent Update

May 22,2020

 

The U.S. Food and Drug Administration is issuing a guidance document to provide additional temporary flexibility in food labeling requirements to manufacturers and vending machine operators. The goal is to provide regulatory flexibility, where appropriate, to help minimize the impact of supply chain disruptions on product availability associated with the current COVID-19 pandemic.

 

Entitled “Temporary Policy Regarding Certain Food Labeling Requirements During the COVID-19 Public Health Emergency: Minor Formulation Changes and Vending Machines,” this guidance is one of several the FDA has issued to provide temporary flexibility to the food industry to help support the food supply chain and meet consumer demand during the pandemic.

 

First, the FDA is providing flexibility for manufacturers to make minor formulation changes in certain circumstances without making conforming label changes, such as making a change to product ingredients, without updating the ingredient list on the packaged food when such a minor change is made. For purposes of this guidance, minor formulation changes should be consistent with the general factors listed below, as appropriate:

 

Safety: the ingredient being substituted for the labeled ingredient does not cause any adverse health effect (including food allergens, gluten, sulfites, or other foods known to cause sensitivities in some people, for example, glutamates);

Quantity: generally present at 2 percent or less by weight of the finished food;

Prominence: the ingredient being omitted or substituted for the labeled ingredient is not a major ingredient in the product;

Characterizing Ingredient: the ingredient being omitted or substituted for the labeled ingredient is not a characterizing ingredient; for example, omitting raisins, a characterizing ingredient in raisin bread;

Claims: an omission or substitution of the ingredient does not affect any voluntary nutrient content or health claims on the label; and

Nutrition/Function: an omission or substitution of the labeled ingredient does not have a significant impact on the finished product, including nutritional differences or functionality.

Specific examples are contained in the guidance. For example, an ingredient could be temporarily reduced or omitted (e.g. green peppers) from a vegetable quiche that contains small amounts of multiple vegetables without a change in the ingredient list on the label. Substitution of certain oils may temporarily be appropriate without a label change, such as canola oil for sunflower oil, because they contain similar types of fats.

 

Another formulation change for which we are providing temporary flexibility is the substitution of “bleached flour.” Some flours require the word “bleached” wherever the name of the food appears on the label. FDA is aware that currently there is a shortage of the bleaching agent used to bleach flour. Given significant supply chain disruptions for this ingredient during this time, FDA is providing temporary flexibility for the substitution of unbleached flour for bleached flour without a corresponding label change while there continue to be bleached flour shortages.

 

The guidance also provides examples of existing flexibilities in food labeling regulations so that manufacturers know these are already available. One example is the flexibility to exchange spices when the label declares the generic term “spice.”

 

Second, the FDA is providing temporary flexibility to the vending machine industry and will not object if covered operators do not meet vending machine labeling requirements to provide calorie information for foods sold in the vending machines at this time. As a result of the COVID-19 pandemic, vending machine operators may need to change business practices, and there may be temporary disruptions in the supply chain for foods sold in vending machines. Where possible, FDA encourages covered vending machine operators to continue to comply with the vending machine labeling requirements.

 

Other temporary flexibilities that FDA has issued address nutrition labeling on food packages, menu labeling, packaging and labeling of shell eggs and the distribution of eggs to retail locations.

Anonymous ID: 838467 July 19, 2022, 6:24 p.m. No.16766043   🗄️.is đź”—kun   >>6124

Bacterial and fungal isolation from face masks under the COVID-19 pandemicScientific Reports (nature.com)

 

https://www.nature.com/articles/s41598-022-15409-x

 

Abstract

The COVID-19 pandemic has led people to wear face masks daily in public. Although the effectiveness of face masks against viral transmission has been extensively studied, there have been few reports on potential hygiene issues due to bacteria and fungi attached to the face masks. We aimed to (1) quantify and identify the bacteria and fungi attaching to the masks, and (2) investigate whether the mask-attached microbes could be associated with the types and usage of the masks and individual lifestyles. We surveyed 109 volunteers on their mask usage and lifestyles, and cultured bacteria and fungi from either the face-side or outer-side of their masks. The bacterial colony numbers were greater on the face-side than the outer-side; the fungal colony numbers were fewer on the face-side than the outer-side. A longer mask usage significantly increased the fungal colony numbers but not the bacterial colony numbers. Although most identified microbes were non-pathogenic in humans; Staphylococcus epidermidis, Staphylococcus aureus, and Cladosporium, we found several pathogenic microbes; Bacillus cereus, Staphylococcus saprophyticus, Aspergillus, and Microsporum. We also found no associations of mask-attached microbes with the transportation methods or gargling. We propose that immunocompromised people should avoid repeated use of masks to prevent microbial infection.

Anonymous ID: 838467 July 19, 2022, 6:38 p.m. No.16766101   🗄️.is đź”—kun   >>6150

>>16766067

 

yes.

'biomedical waste' is a mi$nomer, and there is a material return of free gonad donations on the backend of sexual reassignment surgeries as well.

 

-abortions

-cord and cord blood donations

-sperm donations

-egg donations

-CSF donations

-hysterectomies

-sex changes

 

all PAY to give physsical biological material to those who know the worth and value of such tissues